BMY » Topics » FOR THE PERIOD ENDED DECEMBER 31, 2008

This excerpt taken from the BMY 8-K filed Jan 27, 2009.

FOR THE PERIOD ENDED DECEMBER 31, 2008

(Unaudited, amounts in millions except per share data)

 

QUARTER-TO-DATE

                  
     Growth %     FX
Impact
    Growth %
Excluding FX
 

Net Sales

   4 %   -4 %   8 %

Marketing, selling and administrative

   2 %   5 %   7 %

Advertising and product promotion

   -3 %   3 %   —    

Research and development

   29 %   2 %   31 %

YEAR-TO-DATE

                  
     Growth %     FX
Impact
    Growth %
Excluding FX
 

Net Sales

   13 %   2 %   11 %

Marketing, selling and administrative

   6 %   -2 %   4 %

Advertising and product promotion

   10 %   -2 %   8 %

Research and development

   11 %   -1 %   10 %

 

5


BRISTOL-MYERS SQUIBB COMPANY

This excerpt taken from the BMY 8-K filed Oct 23, 2008.

FOR THE PERIOD ENDED SEPTEMBER 30, 2008

($ in millions)

 

QUARTER-TO-DATE

    
     Pharmaceuticals     Nutritionals     Continuing
Operations
 

Price Increases/(Decreases)

     2 %     9 %     3 %

Foreign Exchange

     3 %     3 %     3 %

Volume

     10 %     -2 %     8 %
                        

Total Change

     15 %     10 %     14 %
                        

Total 2008 Period to Date Sales

   $ 4,510     $ 744     $ 5,254  

Total 2007 Period to Date Sales

   $ 3,926     $ 675     $ 4,601  

YEAR-TO-DATE

    
     Pharmaceuticals     Nutritionals     Continuing
Operations
 

Price Increases

     3 %     9 %     4 %

Foreign Exchange

     4 %     4 %     4 %

Volume

     10 %     1 %     9 %
                        

Total Change

     17 %     14 %     17 %
                        

Total 2008 Period to Date Sales

   $ 13,173     $ 2,175     $ 15,348  

Total 2007 Period to Date Sales

   $ 11,234     $ 1,901     $ 13,135  

 

2


BRISTOL-MYERS SQUIBB COMPANY

This excerpt taken from the BMY 8-K filed Jul 24, 2008.

FOR THE PERIOD ENDED JUNE 30, 2008

($ in millions)

 

QUARTER-TO-DATE       
     Pharmaceuticals     Nutritionals     Continuing
Operations
 

Price Increases/(Decreases)

     3 %     10 %     4 %

Foreign Exchange

     5 %     5 %     5 %

Volume

     8 %     2 %     7 %
                        

Total Change

     16 %     17 %     16 %
                        

Total 2008 Period to Date Sales

   $ 4,475     $ 728     $ 5,203  

Total 2007 Period to Date Sales

   $ 3,851     $ 620     $ 4,471  
YEAR-TO-DATE       
     Pharmaceuticals     Nutritionals     Continuing
Operations
 

Price Increases

     3 %     9 %     4 %

Foreign Exchange

     5 %     5 %     5 %

Volume

     11 %     3 %     9 %
                        

Total Change

     19 %     17 %     18 %
                        

Total 2008 Period to Date Sales

   $ 8,663     $ 1,431     $ 10,094  

Total 2007 Period to Date Sales

   $ 7,308     $ 1,226     $ 8,534  

 

2


BRISTOL-MYERS SQUIBB COMPANY

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki